Skip to main content
Clinical Trials/KCT0006560
KCT0006560
Completed
未知

Effects of the Personalized Self-management Program on Metabolic Syndrome for Prostate Cancer Patients with Androgen Derivation Therapy

Yonsei University0 sites48 target enrollmentTBD
ConditionsNeoplasms

Overview

Phase
未知
Intervention
Not specified
Conditions
Neoplasms
Sponsor
Yonsei University
Enrollment
48
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
September 15, 2021
Last Updated
3 years ago
Study Type
Interventional Study
Sex
Male

Investigators

Eligibility Criteria

Inclusion Criteria

  • (1\) Patients who have received ADT therapy for at least 6 months.
  • (2\) Those with at least one of the five metabolic syndrome factors in the abnormal range.
  • (3\) A person who is fully aware of the purpose and contents of the research and voluntarily participated in the research.
  • (4\) A person who can understand Korean and can communicate without cognitive impairment.

Exclusion Criteria

  • (1\) Those who have been diagnosed with other cancer except for prostate cancer and are being treated.
  • (2\) Those who have undergone surgery or chemotherapy within the last 3 months.
  • (3\) Those who answered yes” to one or more of the Physical Activity Readiness Questionnaires (PAR\-Q).
  • (4\) Those with cardiovascular diseases such as unstable angina pectoris, uncontrolled blood pressure, and myocardial infarction.
  • (5\) Those who have serious complications such as musculoskeletal and nervous system diseases.
  • (6\) Those who participate in other intervention programs or change medication to control blood pressure, cholesterol, and blood sugar within the last 3 months from the initiation time of participation in the program.
  • (7\) Participants who cannot use data due to missing data such as primary variables.
  • (8\) Those who have difficulty in independent activities or daily life.

Outcomes

Primary Outcomes

Not specified

Similar Trials